Colgate-Palmolive Company $CL Shares Purchased by RWA Wealth Partners LLC

RWA Wealth Partners LLC lifted its position in Colgate-Palmolive Company (NYSE:CL) by 33.9% during the 1st quarter, Holdings Channel.com reports. The fund owned 246,846 shares of the company’s stock after acquiring an additional 62,523 shares during the period. RWA Wealth Partners LLC’s holdings in Colgate-Palmolive were worth $23,129,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in the business. Qtron Investments LLC boosted its holdings in Colgate-Palmolive by 5.5% in the first quarter. Qtron Investments LLC now owns 18,173 shares of the company’s stock valued at $1,703,000 after purchasing an additional 953 shares during the last quarter. Aptus Capital Advisors LLC boosted its stake in shares of Colgate-Palmolive by 24.3% during the 1st quarter. Aptus Capital Advisors LLC now owns 21,986 shares of the company’s stock worth $2,060,000 after acquiring an additional 4,296 shares in the last quarter. Summit Securities Group LLC purchased a new stake in shares of Colgate-Palmolive during the 1st quarter worth about $136,000. Freestone Capital Holdings LLC boosted its stake in shares of Colgate-Palmolive by 2.4% during the 1st quarter. Freestone Capital Holdings LLC now owns 43,190 shares of the company’s stock worth $4,047,000 after acquiring an additional 1,004 shares in the last quarter. Finally, Algert Global LLC boosted its stake in shares of Colgate-Palmolive by 32.1% during the 1st quarter. Algert Global LLC now owns 67,176 shares of the company’s stock worth $6,294,000 after acquiring an additional 16,338 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Up 0.4%

Colgate-Palmolive stock opened at $85.02 on Monday. Colgate-Palmolive Company has a fifty-two week low of $82.40 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The firm has a 50 day moving average price of $88.21 and a 200 day moving average price of $89.99. The company has a market capitalization of $68.71 billion, a PE ratio of 23.88, a price-to-earnings-growth ratio of 4.42 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter last year, the firm earned $0.91 EPS. The firm’s revenue for the quarter was up 1.0% on a year-over-year basis. Research analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were given a dividend of $0.52 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. Colgate-Palmolive’s dividend payout ratio is currently 58.43%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on CL shares. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $88.00 to $83.00 and set an “underweight” rating for the company in a research note on Monday, August 4th. JPMorgan Chase & Co. decreased their target price on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Morgan Stanley cut their price target on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a report on Monday, August 4th. UBS Group decreased their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a report on Thursday, July 17th. Finally, Citigroup decreased their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a report on Monday, August 4th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $98.92.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.